Cloth, Chlorhexidine Gluconate Pre-Op Prep
ID: MS-2407-46Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/164ee17f7b744305a88ec7dcf936099f/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.

    Point(s) of Contact
    MMESO Enterprise Wide Standardization
    dha.detrick.med-log.mbx.mmeso@mail.mil
    Tara J. Perrien, Contracting Officer
    tara.perrien@dla.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Currently viewing
    Presolicitation
    Similar Opportunities
    Chlorhexidine Gluconate (CHG) Applicators, Procedural
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to supply Chlorhexidine Gluconate (CHG) Applicators, Procedural, as part of a Combined Synopsis/Solicitation. Vendors are required to submit detailed pricing and product specifications, including compliance with the Qualified Suppliers List (QSL) and adherence to the Distribution and Pricing Agreement (DAPA), to support Military Treatment Facilities (MTFs) across various branches of the military. This procurement action is crucial for standardizing medical supplies and ensuring efficient healthcare delivery within the defense sector, with an estimated annual demand valued at approximately $812,275.77. Interested vendors must submit their proposals by March 6, 2025, and can direct inquiries to Mr. Arthur B. Redmond at arthur.b.redmond.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil.
    Chlorhexidine Gluconate (CHG) Applicators, Surgical
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency's DLA Troop Support, is seeking vendors to supply Chlorhexidine Gluconate (CHG) applicators for surgical use, as part of a standardization initiative aimed at Military Treatment Facilities. Vendors must be listed on the Qualified Suppliers List and are required to submit detailed pricing information and product specifications, with the goal of establishing a sole vendor for a five-year Incentive Agreement based on the lowest price. The annual demand for these applicators is estimated at approximately $908,392.36, reflecting the importance of standardizing medical supplies within the Military Health System. Interested vendors should contact Mr. Arthur B. Redmond at arthur.b.redmond.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil for further details and ensure compliance with submission deadlines to participate in this procurement opportunity.
    Skin Staplers
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Staplers, with a presolicitation notice expected to be released on or about February 9, 2025. This initiative aims to solicit information and products for evaluation, focusing on sterile, single patient use skin staplers designed for external skin closure, while excluding reloadable, reprocessed, absorbable, or rotating head staplers. The selected products must comply with the Trade Agreements Act (TAA) and be manufactured in compliant countries, with all vendors required to have a Distribution and Pricing Agreement (DAPA) and an active account in the System for Award Management (SAM). For further details, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or refer to the DLA website for additional information regarding the MSPV program.
    Vaginal Specula Disposable
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    Specimen Container Peel Pack
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Pulse Oximeter-Fingertip (Non-Aeromedical Certified)
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking vendors to establish a Qualified Suppliers Listing (QSL) for Pulse Oximeter-Fingertip (Non-Aeromedical Certified) devices. This procurement aims to standardize medical equipment utilized by Military Treatment Facilities (MTFs) across the armed forces, with an anticipated annual sales volume of approximately $107,760. Eligible vendors must possess a Defense Medical Materiel (DMM) number, a Distribution and Pricing Agreement (DAPA), and comply with FDA regulations, including the exclusion of natural rubber latex in their products. Interested parties should complete the QSL Package Worksheet by March 13, 2025, and will be invited to submit pricing quotes around May 8, 2025. For further inquiries, vendors can contact Mr. Riley Whittlesey at riley.w.whittlesey.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.
    REQUEST FOR INFORMATION (RFI) FOR MARKET RESEARCH FOR THE MEDICAL/SURGICAL PRIME VENDOR PROGRAM - DLA TROOP SUPPORT
    Buyer not available
    The Defense Logistics Agency (DLA) is conducting a Request for Information (RFI) to gather market research for the Medical Surgical Prime Vendor Program (Med/Surg PV), aimed at developing an acquisition strategy for a long-term, indefinite quantity contract. This initiative is critical for providing a comprehensive range of medical and surgical supplies to designated Medical Treatment Facilities (MTFs) through a single distribution channel, ensuring next-day delivery of both brand name and generic products. Interested vendors are invited to respond to the RFI by February 28, 2025, with submissions directed to Beatrice Lopez-Pollard, Contracting Officer, via mail or email at beatrice.lopez-pollard@dla.mil. The information collected will inform the contract formation process while safeguarding proprietary submissions.
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Doxycycline Hyclate
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Doxycycline Hyclate. The contract will establish a national supply source to provide Doxycycline Hyclate 100MG Tablets in various bottle sizes. This acquisition is for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be firm-fixed price, requirements type with a one year base and four one year options. Interested parties should contact Catherine Gilbert for more information. The projected solicitation date is September 2019.